---
title: "Shouyao Holdings Co., LTD. (688197.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688197.SH.md"
symbol: "688197.SH"
name: "Shouyao Holdings Co., LTD."
industry: "Pharmaceuticals"
datetime: "2026-05-20T15:31:00.816Z"
locales:
  - [en](https://longbridge.com/en/quote/688197.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688197.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688197.SH.md)
---

# Shouyao Holdings Co., LTD. (688197.SH)

## Company Overview

Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of innovative drugs in China. The company offers drugs for various indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, China.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | CN Market |
| Website | [www.shouyaoholding.com](https://www.shouyaoholding.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:11.000Z

**Overall: C (0.42)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 124 / 215 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 483.43% |  |
| Net Profit YoY | 55.50% |  |
| P/B Ratio | 9.44 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 6291588868.76 |  |
| Revenue | 34729237.41 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -13.09% | D |
| Profit Margin | -268.76% | E |
| Gross Margin | 100.00% | A |
| Revenue YoY | 483.43% | A |
| Net Profit YoY | 55.50% | B |
| Total Assets YoY | -10.71% | E |
| Net Assets YoY | -12.29% | E |
| Cash Flow Margin | 123.81% | B |
| OCF YoY | 483.43% | A |
| Turnover | 0.04 | E |
| Gearing Ratio | 13.91% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Shouyao Holdings Co., LTD.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "483.43%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "55.50%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "9.44",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "6291588868.76",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "34729237.41",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-13.09%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-268.76%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "100.00%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "483.43%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "55.50%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "-10.71%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-12.29%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "123.81%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "483.43%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.04",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "13.91%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -67.61 | 207/215 | - | - | - |
| PB | 9.47 | 209/215 | 9.43 | 8.83 | 8.17 |
| PS (TTM) | 181.72 | 222/215 | 2825.77 | 2592.49 | 963.84 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Allist (688578.SH) | A | A | B | A | B | A |
| 02 | Xingqi Pharmaceutical (300573.SZ) | A | A | A | A | B | A |
| 03 | Hengrui Pharma (600276.SH) | A | B | C | A | B | B |
| 04 | Yunnan Baiyao (000538.SZ) | B | C | B | B | C | B |
| 05 | Haisco (002653.SZ) | A | A | B | B | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2025-05-14T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 42.36 |
| Highest Target | 49.00 |
| Lowest Target | 49.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688197.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688197.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688197.SH/news.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**